Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy
In Cancer Immunology, Immunotherapy, 2009
... cells (MUTZ3-LC) were cultured from MUTZ-3 progenitors with 10 ng/ml TGF-β1 (Biovision, Mountain View, CA), 1,000 IU/ml rhGM-CSF (Sagramostim, Berlex), and 120 IU/ml TNFα (Miltenyi Biotec, Bergisch Gladbach, Germany) for ... A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling.more suppliers
In PLoS ONE, 2002
... against CD3, CD4, CD27, CD28, CD45-RA, CD45-RO, CD57, CD62-L, IL-2, IL-4, IL-5, IL-13, TNF-α, IFN-γ, GM-CSF from BD Biosciences, CD8α, CD8β, TCRαβ, Vβ1, ...
DEL1 - a new player in periodontal disease?
Toronto, Canada. In Oral Dis, Feb 2016
Osteoblasts (as well as osteocytes and stromal cells) secrete two key molecules, macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor κB ligand (RANKL), which activate the fusion of the mononuclear precursors to form mature multinucleated osteoclasts.
Neutrophil ageing is regulated by the microbiome.
New York City, United States. In Nature, Oct 2015
Aged neutrophils upregulate CXCR4, a receptor allowing their clearance in the bone marrow, with feedback inhibition of neutrophil production via the IL-17/G-CSF axis, and rhythmic modulation of the haematopoietic stem-cell niche.
Genome-wide transcription profiling in neutrophils in acute respiratory distress syndrome.
Cambridge, United Kingdom. In Lancet, Mar 2015
METHODS: GeneChip Affymetrix oligonucleotide arrays were used to assess global transcriptional profiles in highly pure PMNs from ventilated patients fulfilling the Berlin ARDS definition (n=10), in freshly isolated PMNs from age-matched and sex-matched healthy volunteers (n=10), and in healthy volunteer PMNs exposed in vitro to recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) (1 ng/mL for 6 h).
The Human Experience with Intravenous Levodopa.
More papers using
Saint Louis, United States. In Front Pharmacol, 2014
At least 2760 subjects have received IV levodopa, and reported outcomes include parkinsonian signs, sleep variables, hormone levels, hemodynamics, CSF amino acid composition, regional cerebral blood flow, cognition, perception and complex behavior.